IDH1 突变实体瘤的临床试验
总计5271个结果
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
Samsung Medical Center完全的
-
Odonate Therapeutics, Inc.终止
-
Novartis Pharmaceuticals完全的
-
Atridia Pty Ltd.完全的
-
PfizerMerck Sharp & Dohme LLC完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
OSI Pharmaceuticals完全的
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)终止
-
SCRI Development Innovations, LLCBayer完全的
-
Merck KGaA, Darmstadt, Germany完全的
-
Vertex Pharmaceuticals IncorporatedNational Cancer Institute (NCI)撤销
-
Syndax Pharmaceuticals完全的
-
Dr David ZieglerEngeneic Pty Limited终止
-
Spago Nanomedical AB招聘中
-
Jazz Pharmaceuticals完全的